Milovancev, Milan <br/><br/>
Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.  [electronic resource] 

 -  BMC veterinary research  Jun 2016 
 - 85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1746-6148 
<br/><br/><label>Standard No.: </label>10.1186/s12917-016-0712-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzamides<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Dog Diseases--drug therapy<br/>Dogs<br/>Doxorubicin--therapeutic use<br/>Fibrosarcoma--drug therapy<br/>Imatinib Mesylate--therapeutic use<br/>Mouth Neoplasms--drug therapy<br/>Piperidines<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-kit--metabolism<br/>Pyridines<br/>Receptor, Platelet-Derived Growth Factor alpha--antagonists & inhibitors<br/>Receptor, Platelet-Derived Growth Factor beta--antagonists & inhibitors<br/>Thiazoles--therapeutic use<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors